Maree Zinzley, Manager Approvals Operations of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“the Act”), that the following application has been made to register a trade name product under section 9(1) of the Act:

Trade Name: Biobos IBR Marker Vaccine

Reference: A11239

Active Ingredient and Concentration:

Bovine herpesvirus type 1. (Inactivated). Each 2mL dose contains RP ≥ 1. Relative Potency (RP) established by serological method (ELISA) in comparison with standard vaccine with minimal content of antigen.

Formulation Type: Aqueous suspension

General Use Claim:

Vaccine for cattle containing inactivated Bovine herpesvirus type 1 (BoHV-1).

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:

1. must state in full the reasons for making the submission; and
2. may state any decision sought on that application; and
3. must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.

The following address is:

1. where submissions on this application are to be sent; and
2. where requests for copies of the public information relating to the application can be sent; and
3. where public information relating to the application can be viewed; and
4. the director-general’s address for service:

ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.

The applicant’s address for service is:

Laura Young, 1.2/89 Grafton Road, Grafton, Auckland 1010.

Dated at Wellington this 8th day of September 2015.

MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).